Condition
Human Papilloma Virus (HPV) Vaccine
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting1
Suspended1
Clinical Trials (2)
Showing 2 of 2 trials
NCT05677360Not ApplicableSuspendedPrimary
HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)
NCT06743880Not Yet RecruitingPrimary
Knowledge, Attitude &practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
Showing all 2 trials